wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26768665-4F9C21E4-65E3-4374-8F53-1BDB62A940AC
Q26768665-4F9C21E4-65E3-4374-8F53-1BDB62A940AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26768665-4F9C21E4-65E3-4374-8F53-1BDB62A940AC
ABC3 Consensus Commented from the Perspective of the German Guidelines
P2860
Q26768665-4F9C21E4-65E3-4374-8F53-1BDB62A940AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26768665-4F9C21E4-65E3-4374-8F53-1BDB62A940AC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6f160484845e5f25af70cc8aa7427228ef9ef26c
P2860
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).